Shanghai Kehua Bio-Engineering Receives Medical Device Registration Certificate for Complement C1q Assay Kit

Stock News

07/03

Shanghai Kehua Bio-Engineering Co.,Ltd. (ASX: 002022) has announced that it has obtained a Medical Device Registration Certificate for an in-vitro diagnostic reagent from the Shanghai Municipal Medical Products Administration.

The registered product is the Complement C1q Assay Kit (Latex Immunoturbidimetric Method).

This kit is intended for use by medical institutions to conduct the quantitative in-vitro determination of Complement C1q levels in human serum and plasma samples.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1166409779"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166409779\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166409779?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 16:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166409779","market":"hk","top_or_hot":-1,"title":"Shanghai Kehua Bio-Engineering Receives Medical Device Registration Certificate for Complement C1q Assay Kit","media":"Stock News","content":"<p><b>Shanghai Kehua Bio-Engineering Co.,Ltd.</b> (<b>ASX: 002022</b>) has announced that it has obtained a Medical Device Registration Certificate for an in-vitro diagnostic reagent from the Shanghai Municipal Medical Products Administration.<br><br>The registered product is the Complement C1q Assay Kit (Latex Immunoturbidimetric Method).<br><br>This kit is intended for use by medical institutions to conduct the quantitative in-vitro determination of Complement C1q levels in human serum and plasma samples.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Kehua Bio-Engineering Receives Medical Device Registration Certificate for Complement C1q Assay Kit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Kehua Bio-Engineering Receives Medical Device Registration Certificate for Complement C1q Assay Kit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-07-03 16:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>Shanghai Kehua Bio-Engineering Co.,Ltd.</b> (<b>ASX: 002022</b>) has announced that it has obtained a Medical Device Registration Certificate for an in-vitro diagnostic reagent from the Shanghai Municipal Medical Products Administration.<br><br>The registered product is the Complement C1q Assay Kit (Latex Immunoturbidimetric Method).<br><br>This kit is intended for use by medical institutions to conduct the quantitative in-vitro determination of Complement C1q levels in human serum and plasma samples.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0188","symbol_name":"融資沽空","start_time":0,"source_url":"","article_id":"1166409779","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166409779","pubTimestamp":1783066349,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Kehua Bio-Engineering Co.,Ltd. (ASX: 002022) has announced that it has obtained a Medical Device Registration Certificate for an in-vitro diagnostic reagent from the Shanghai Municipal...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","BK0188":"融资融券","BK1574":"生物医药B类股","BK0028":"国家队","002022":"科华生物","BK0046":"生物疫苗","BK1583":"高瓴概念","09996":"沛嘉医疗-B","BK1100":"医疗保健设备","BK0239":"医药制造"},"translate_title":"上海科华生物工程补体C1q检测试剂盒获医疗器械注册证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"002022":1,"09996":1},"content_text":"Shanghai Kehua Bio-Engineering Co.,Ltd. (ASX: 002022) has announced that it has obtained a Medical Device Registration Certificate for an in-vitro diagnostic reagent from the Shanghai Municipal Medical Products Administration.The registered product is the Complement C1q Assay Kit (Latex Immunoturbidimetric Method).This kit is intended for use by medical institutions to conduct the quantitative in-vitro determination of Complement C1q levels in human serum and plasma samples.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}